Targets of Tumor Immunity After Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-0857
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Outcomes of Lung Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Allogeneic Hematopoietic Stem Cell Transplantation

Archives of Internal Medicine
2002English

Kaposi's Sarcoma Developed After Allogeneic Hematopoietic Stem Cell Transplantation

Oncology Letters
Cancer ResearchOncology
2011English

Late-Onset Cerebral Toxoplasmosis After Allogeneic Hematopoietic Stem Cell Transplantation

American Journal of Case Reports
Medicine
2017English

Challenging Diagnosis of Hemosiderosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Management of Adenovirus in Children After Allogeneic Hematopoietic Stem Cell Transplantation

Advances in Hematology
Hematology
2013English

Early Lung Computed Tomography Scan After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

DNA Virus Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation (Allo-Hsct)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Extramedullary Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy